Search Results
Jan 06, 2026, 10:01 ET Data Featuring Haystack MRD® from Quest Diagnostics to be Presented at the 2026 ASCO Gastrointestinal Cancers Symposium
Patients with Resected Colorectal Cancer from the DYNAMIC TrialsAbstract Number: 26 Lead Author: Jeanne Tie, MBChB, FRACP, MD Session Time and Date: 1/10/2026, 12:00 PM-1:30 PM (PST)Title: Use of circulating tumor DNA (ctDNA) to
More news about: Quest Diagnostics
Jan 06, 2026, 10:00 ET Endeavor Health part of first-of-its-kind trial to diagnose CTE in live patients
Julian Bailes, MD, Arlene and Marshall Bennett and Joseph A. Tarkington, MD, Chair of Neurosurgery at Endeavor Health Neurosciences Institute, who has been studying CTE for more than 20 years. "You
More news about: Endeavor Health
Jan 06, 2026, 10:00 ET First Patients Enrolled in Groundbreaking Brain Cancer Study at Nationally Recognized Academic Medical Center
degree of efficacy or the limitations of our therapies, while preventing the trauma and costs of repeated brain surgery," said Dr. Annick Desjardins, MD, FRCPC, neuro-oncologist, professor of neurosurgery and neurology at Duke University and the study's principal investigator."Serial tumor sampling
More news about: Exvade Bioscience, Inc.
Jan 06, 2026, 09:30 ET Lung Cancer Research Foundation Announces Additional 2025 Scientific Research Grant Awards
immunotherapies but will also provide essential advancement in the non-invasive biomarker development investigating therapy resistance.Joseph Chan, MD, PhD, Memorial Sloan Kettering Cancer CenterBiomarkers of Response and Toxicity to Tarlatamab in Patients with Metastatic Small Cell Lung
More news about: Lung Cancer Research Foundation
Jan 06, 2026, 09:26 ET Gilgamesh Pharma Announces Positive Topline Phase 2a Results for Blixeprodil (GM-1020) in Major Depressive Disorder
patient experience," said Jonathan Sporn, MD, CEO and Co-Founder of Gilgamesh Pharma."The data from this study are particularly compelling as blixeprodil demonstrates both impressive efficacy and a favorable safety profile," said Dr. Gerard Sanacora, MD, PhD, Director of the Yale Depression Research
More news about: Gilgamesh Pharma
Jan 06, 2026, 09:00 ET Mezzion Pharmaceuticals Appoints Physician-Scientist Ridwan Shabsigh, MD, FACS as President & Chief Operating Officer
people born with single ventricle congenital heart disease (SV-CHD) living with Fontan circulation, today announced the appointment of Ridwan Shabsigh, MD, FACS to the newly created role of President and Chief Operating Officer.
More news about: Mezzion Pharmaceuticals, Inc
Jan 06, 2026, 09:00 ET Alley Cat Rescue Pushes for Action Against State-sponsored Killing of Feral Cats in New Zealand
MT. RAINIER, Md., Jan. 6, 2026 /PRNewswire/ -- New Zealand's Predator Free 2050 Program is a national, government-run effort to cull introduced species the Department of Conservation considers to be threats to native wildlife.
More news about: Alley Cat Rescue, Inc.
Jan 06, 2026, 09:00 ET Choice Hotels International Accelerates Growth in Canada with Six New Ascend Collection Properties in Québec
consolidation of Choice Hotels Canada and strengthens its presence across resort destinations.NORTH BETHESDA, Md., Jan. 6, 2026 /PRNewswire/ -- Choice Hotels International, Inc. (NYSE: CHH) announced the expansion of its upscale
More news about: Choice Hotels International, Inc.
Jan 06, 2026, 09:00 ET 2026 AFP FP&A Forum to Deliver Practical Solutions to Today's Most Pressing Corporate Finance Challenges
Financial Professionals (AFP), the in-person event will be held in Indianapolis, March 23-25, 2026ROCKVILLE, Md., Jan. 6, 2026 /PRNewswire/ -- The
More news about: Association for Financial Professionals
Jan 06, 2026, 09:00 ET Origin℠ AI and Synaptics Team Up to Accelerate Smart Home Innovation With Embedded WiFi Sensing
connectivity solutions to enable seamless and scalable integration in the smart home ecosystem.ROCKVILLE, Md., Jan. 6, 2026 /PRNewswire/ -- Origin℠ AI, the inventors of AI Sensing℠, today announced a strategic partnership
More news about: Origin AI
Jan 06, 2026, 09:00 ET BillionToOne Announces Selection of Northstar Select® as the new liquid biopsy test for LC-SCRUM-TRY clinical study at National Cancer Center Hospital East
cancer patients in Japan, and we are excited to launch the next phase of LC-SCRUM-TRY through our collaboration with BillionToOne," said Koichi Goto, MD, PhD (Deputy Director, NCCHE). "By integrating the highly sensitive Northstar Select liquid biopsy into the study, we expect to find more opportunities
More news about: BillionToOne
Jan 06, 2026, 09:00 ET The Reeve Foundation and Spinal Research Award New Grants to Advance Traumatic Spinal Cord Injury Treatments
Michael Fehlings, MD, PhD, FRCSC, FACS, Professor of Neurosurgery and Co-Director of the Spinal Program at the University of Toronto, will advance a new stem cell–based strategy
More news about: Christopher & Dana Reeve Foundation
Jan 06, 2026, 08:53 ET NanOlogy Appoints John M. Goldberg, MD as Chief Medical Officer to Further its Preclinical & Clinical Large Surface Area Microparticle Investigational Drug Portfolio
NanOlogy, LLC, a clinical-stage oncology company, today announced the appointment of John M. Goldberg, MD as fractional Chief Medical Officer (CMO) to advance development of its Large Surface Area Microparticle (LSAM) drug portfolio including its development
More news about: NanOlogy LLC
Jan 06, 2026, 08:52 ET RESA Power Expands Its Transformer Solutions Capabilities with the Acquisition of 3MD Power Services LLC
electrical testing, transformer services, and life extension solutions for power distribution equipment, has acquired 3MD Power Services LLC ("3MD"). Based in Roanoke, Virginia, 3MD has provided high voltage testing, repair, maintenance, and installation of large power transformers across the USA
More news about: RESA Power
Jan 06, 2026, 08:51 ET Egglife Announces Northeast Costco Launch with Value-sized 18-count Original Egg White Wraps
Northeast with a new value-sized 18-count pack of its hero product, Original egglife® EGG WHITE WRAPSs. Rolling out across Costco locations in CT, MA, MD, NY, NJ, PA, VA, VT, and ME, this Costco-exclusive pack (SRP: $10.99) delivers even more convenience and value for shoppers seeking high-protein, low-carb
More news about: Egglife Foods, Inc.
Jan 06, 2026, 08:35 ET NAPA Anesthesia Expands Bon Secours Relationship to Mary Immaculate Hospital
anesthetist (CRNA) team minimizes call and weekend requirements for the department."Our first priority is people and culture," said Matt Walsh, MD, NAPA's Clinical Regional Senior Vice President. "We're building a high-trust, high-performance team at Mary Immaculate, anchored by a strong local
More news about: NAPA Management Services Corporation
Jan 06, 2026, 08:33 ET ELTA North America Awarded $11 Million to Provide Airborne Communications Jammers
Awarded $11M Contract to Develop and Produce Airborne Communications JammersANNAPOLIS JUNCTION, Md., Jan. 6, 2026 /PRNewswire/ -- ELTA North America, a U.S.-based defense company headquartered in Maryland, has
More news about: ELTA North America
Jan 06, 2026, 08:30 ET HUYABIO International Presents Positive Clinical Results from HBI-3000, a Novel Multi-ion Channel Blocker for Acute Atrial Fibrillation
indicates high potential for treatment of atrial fibrillation with improved safety, including freedom from proaarhythmic effects.Professor John Camm, MD said, "Sulcardine has a balanced inhibitory effect on several atrial and ventricular ion channels responsible for serious cardiac arrhythmias. The predominant
More news about: HUYABIO International
Jan 06, 2026, 08:30 ET 'Scripting Possibilities' in Biotechnology: Global Innovators Converge in San Francisco for GenScript's 5th Annual Biotech Forum During JPM Week
molecules and therapeutic modalities once thought impossible and fundamentally redefining how medicines can be engineered.Eric Horvitz, PhD, MD, Chief Scientific Officer, Microsoft. Dr. Horvitz is a trailblazer in artificial intelligence and responsible AI, driving advancements that are influencing
More news about: GenScript Biotech Corporation
Jan 06, 2026, 08:14 ET Pacific Mind Health Launches Free Gratitude Journal to Support Calm and Mental Clarity
JOURNAL"Research shows that even brief daily reflections can improve mood, reduce stress, and support emotional resilience," said Joshua Flatow, MD, medical director and chief psychiatrist at Pacific Mind Health. "Our gratitude journal offers a simple way to build that habit with warmth and self-compassion."The
More news about: Pacific Mind Health
Jan 06, 2026, 08:00 ET Curio Wellness Appoints Matt O'Neal as Regional President, Midwest
Appointment Strengthens Market Leadership, Wholesale Partnerships, and Regional GrowthTOWSON, Md., Jan. 6, 2026 /PRNewswire/ --
More news about: Curio Wellness
Jan 06, 2026, 08:00 ET Novo Nordisk unveils the inaugural State of Weight and Health Report™, offering new insights that shed light on America's obesity epidemic
point to the urgent need for more inclusive, compassionate approaches to obesity care that are tailored to individual circumstances," said Holly Lofton, MD, Director of NYU Langone Health Weight Management Program and member of the report expert panel. "In taking a comprehensive look at how real-world challenges
More news about: NOVO NORDISK INC.
Jan 06, 2026, 07:48 ET ELIXIR MD Inc. Announces Strategic Partnership with H/K/B Cosmetic Surgery to Advance Post-Surgical Recovery Innovation
Mid-Atlantic region, recognized for its education-centered, standardized approach to care delivery.About ELIXIR MD Inc.Based in Irvine, California, ELIXIR MD Inc. is pioneering plastic surgery patient recovery. We operate in 19 countries with a growing portfolio of proprietary devices,
More news about: ELIXIR MD™
Jan 06, 2026, 07:19 ET FDA Grants Orphan Drug Designation to Cellenkos' CK0804 Treg Therapy for Treatment of Myelofibrosis
CK0804 into phase 2 trials to address the unmet need for patients who have not responded to currently available therapies", said Dr. Simrit Parmar, MD, Founder of Cellenkos. "The observed increase in IL-10 and decreases in TGFβ levels in CK0804 responders, together with reductions in pathogenic
More news about: Cellenkos, Inc.
Jan 06, 2026, 07:00 ET AbelZeta to Attend 44th Annual J.P. Morgan Healthcare Conference and Join Panel Discussion
ROCKVILLE, Md., Jan. 6, 2026 /PRNewswire/ -- AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary cell-based
More news about: AbelZeta Pharma, Inc.